PGEN
NASDAQ · Biotechnology
Precigen Inc
$4.22
-0.84 (-16.52%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,619.7% upside
Low Target
$43.64
Average Target
$72.57
High Target
$99.14
Current Price
$4.22
Current
$4.22
$4.22
Target
$72.57
$72.57
$43.64
$72.57 avg
$99.14
Scenario Analysis
Bear Case
$43.64
934.1%
Low target
Base Case
$72.57
+1,619.7%
Avg target
Bull Case
$99.14
+2,249.3%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$8.98
-53.0% from high
52-Week Low
$3.04
+38.8% from low
50-Day SMA
$6.98
-39.5% vs SMA
200-Day SMA
$5.28
-20.1% vs SMA
RSI (14)
28.9
Oversold
Target vs 52W High
$72.57
+708.1% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $0.08
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |